| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| bluebird bio, Inc. | Director | Common Stock | 0 | $0 | $4.88 | 02 Jun 2025 | Direct |
| Decibel Therapeutics, Inc. | Chief Financial Officer | Stock Options (right to buy) | 52,500 | 25 Feb 2022 | Direct | ||
| bluebird bio, Inc. | Director | Stock Option (right to buy) | 49,850 | 06 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BLUE | bluebird bio, Inc. | 30 May 2025 | 2 | $0 | 4 | Director | 03 Jun 2025, 17:29 |
| BLUE | bluebird bio, Inc. | 06 Nov 2024 | 2 | $0 | 4 | Director | 08 Nov 2024, 16:08 |
| BLUE | bluebird bio, Inc. | 16 Jun 2023 | 2 | $0 | 4 | Director | 20 Jun 2023, 16:30 |
| BLUE | bluebird bio, Inc. | 17 Oct 2022 | 1 | -$6,490 | 4 | Director | 09 Mar 2023, 15:06 |
| BLUE | bluebird bio, Inc. | 22 Jun 2022 | 2 | $0 | 4 | Director | 23 Jun 2022, 18:08 |
| /report/000089924322008087-leiderman-elisabeth-2022-02-25 | Decibel Therapeutics, Inc. | 25 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 28 Feb 2022, 15:37 |
| BLUE | bluebird bio, Inc. | 11 Nov 2021 | 2 | $0 | 4 | Director | 16 Nov 2021, 05:26 |
| BLUE | bluebird bio, Inc. | 15 Oct 2021 | 2 | $0 | 4 | Director | 19 Oct 2021, 20:00 |
| BLUE | bluebird bio, Inc. | 15 Oct 2021 | 0 | $0 | 3 | Director | 19 Oct 2021, 19:57 |